Poloxamer 407
It has been widely studied for its potential applications in drug delivery, tissue engineering, and personal care products.
This versatile compound exhibits temperature-dependent solubility, forming viscous gels at physiological temperatures.
Researchers can leverage PubCompare.ai's innovative AI-driven platform to streamline their Poloxamer 407 projects, easily locating relevant protocols from literature, preprints, and patents, and leveraging powerful comparisons to identify the most effective products and procedures.
Optimie your Poloxamer 407 research process and take your projects to new heights with this cutting-edg solution.
Most cited protocols related to «Poloxamer 407»
Brine shrimp larvae were initially exposed to different UBO and CNO emulsions dilutions (emulsion: saline water) for 24 h (
After 24 h of exposure, the death rate (the larvae without visible movements in their experimental pots were considered dead) was the measurable parameter for quantifying larvae response to the various concentrations of CNO and UBO. These effects were also evaluated using microscopy with different magnifications and compared with negative controls.
The second step of the BSL assay consisted of lower dilutions preparation: 1:1, 1:2, 1:3, 1:4 from stock UBO and CNO emulsions in 0.3% saline aqueous solution (
Japanese white rabbits (2-2.5 kg) were housed in an approved animal care center and were provided with standard chow and water ad libitum. The laboratory animal ethics committee and laboratory animal centre of Wenzhou Medical University approved all rabbit studies.
Most recents protocols related to «Poloxamer 407»
Example 4
A composition comprising Tretinoin as active ingredient:
The process for the preparation of the composition was as follows:
-
- 1. CMC Na (carboxymethyl cellulose sodium) and Natrosol (HEC) were dispersed in water until a clear gel was formed
- 2. Glycerin and benzyl alcohol were added to stage 1 and mixed;
- 3. Oleic acid, isopropanol, BHT, sorbic acid, Poloxamer 407 and tretinoin were heated to 50° C. while stirring until clear solution was obtained. Then the solution was cooled to the room temperature;
- 4. Silica Microspheres were added to the cooled oily phase and resultant mixture was stirred for at least one hour;
- 5. Stage 4 was added to the stage 2 and stirred for one hour under vacuum.
An opaque yellowish gel was obtained.
Example 3
A composition comprising Tretinoin as active ingredient:
The process for the preparation of the composition was as follows:
-
- 1. Poloxamer 407 A was added to the water while stirring at high speed using mixer propeller;
- 2. The mixture of oleic acid, isopropanol, BHT, sorbic acid, Poloxamer B and tretinoin was heated to 50° C. while stirring and then was cooled to the room temperature;
- 3. Silica Microspheres were added to the stage 2 and resultant mixture was stirred for at least one hour;
- 4. Benzyl alcohol and glycerin were added to stage 1 and stirred;
- 5. Stage 3 was added to the mixer reactor and stirred vigorously;
- 6. Sodium hydroxide was added for pH adjustment.
An opaque yellowish gel was obtained.
Example 3
The method of any one or more of Examples 1 through 2, wherein the humidity tolerant adhesive material comprises a blend of poloxamers.
Example 4
The method of Example 3, wherein the poloxamers are selected from the group consisting of: poloxamer 188; Synperonic® PE/P84; poloxamer 124; poloxamer 407; and combinations thereof.
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Top products related to «Poloxamer 407»
More about "Poloxamer 407"
This versatile compound has garnered significant attention for its unique thermoreversible gelation properties, making it a popular choice in drug delivery, tissue engineering, and personal care applications.
Poloxamer 407 exhibits temperature-dependent solubility, forming viscous gels at physiological temperatures, which can be leveraged to improve the bioavailability and controlled release of various pharmaceutical and cosmetic ingredients.
Researchers often combine Poloxamer 407 with other excipients, such as Tween 80, FBS, Pluronic F-127, Poloxamer 188, DMSO, and Acetonitrile, to optimize its performance and tailor the formulation to specific needs.
To streamline Poloxamer 407 research, researchers can utilize PubCompare.ai's innovative AI-driven platform.
This cutting-edge solution allows users to easily locate relevant protocols from literature, preprints, and patents, and leverage powerful comparisons to identify the most effective products and procedures.
By optimizing the research process, researchers can take their Poloxamer 407 projects to new heights and enhance the reproducibility of their findings.
Whether you're working on drug delivery systems, tissue engineering constructs, or personal care formulations, PubCompare.ai's AI-powered platform can help you navigate the vast landscape of Poloxamer 407 research and unlock new possibilities for your projects.
Embrace this innovative solution and elevtate your Poloxamer 407 research to new levels of efficiency and success.